piracetam has been researched along with Neuroblastoma in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ju, IG | 1 |
| Hong, SM | 1 |
| Yun, SW | 1 |
| Huh, E | 1 |
| Kim, DH | 1 |
| Kim, SY | 1 |
| Oh, MS | 1 |
| Verma, DK | 1 |
| Gupta, S | 1 |
| Biswas, J | 1 |
| Joshi, N | 1 |
| Sivarama Raju, K | 1 |
| Wahajuddin, M | 1 |
| Singh, S | 1 |
2 other studies available for piracetam and Neuroblastoma
| Article | Year |
|---|---|
CCL01, a novel formulation composed of
Topics: Animals; Cell Line, Tumor; Cuscuta; Cyclic AMP Response Element-Binding Protein; Extracellular Signa | 2021 |
Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.
Topics: Animals; Annexin A5; Apoptosis Inducing Factor; Caspases; Cell Line, Tumor; Cell Nucleus Size; Comet | 2018 |